Moisturizer study for ichthyosis
Part of Genetic & congenital, Skin clinical trials.
This study tests a new moisturizer called Doublebase Once, applied once daily, to see if it is safe and works well for people with ichthyosis. Participants will use the study moisturizer for one month instead of their usual one.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ichthyosis (any type or severity), diagnosed by a doctor or nurse.
- You normally use a leave-on moisturizer regularly to manage your skin.
- You are willing to switch to Doublebase Once, using it once daily for one month.
- You do not have a known allergy or sensitivity to any ingredient in Doublebase Once.
- You are not taking part in another clinical trial right now or within the last 30 days.
- You are not currently living in Northern Ireland.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.
This trial tests if gentamicin injections can improve symptoms of hereditary ichthyosis, a genetic skin condition. It is for adults with moderate to severe forms caused by specific gene mutations.
This study tests a moisturizer called Doublebase Once for people with atopic eczema. You apply it once a day for 4 weeks to see how well it improves skin moisture and eczema symptoms.
This trial compares two creams to see which one improves skin barrier function and quality of life better for ichthyosis patients. You would apply either the cholesterol cream or the urea cream daily for a period to find out if one works better than the other.
This trial compares two moisturizers for people with eczema (moderate rash) and healthy volunteers. It looks at how well they work and how the skin tolerates them after using a steroid cream.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
Hear when a new Ichthyosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.